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A major breakthrough in understanding diabetes mellitus, 
especially in the disease cystic fibrosis (CF) was made re-
cently by the group of Dr. Hsiao Chang Chan from the Epi-
thelial Cell Biology Research Center, Key Laboratory of 
Regenerative Medicine of Ministry of Education of China, 
the Chinese University of Hong Kong, Hong Kong, China. 
Their studies were reported recently in Guo et al. [1].  
CF is caused by mutations in the Cl channel, Cystic Fi-
brosis Transmembrane conductance Regulator (CFTR). 
Most often diabetes mellitus is a result of impaired glucose 
tolerance, which is common complications of CF. However, 
although we know quite well how glucose causes insulin 
secretion to control body energetics, we do not know how 
impaired CFTR activity leads to cystic fibrosis-related dia-
betes (CFRD) and potential role of CFTR in other forms of 
diabetes. 
Glucose causes insulin secretion by entering into β cells 
in the islands of Langerhans. In β cells, glucose is converted 
to ATP, and the increased ATP inhibits an inward rectifying 
K+ channel to depolarize the cells. The depolarization acti-
vates a voltage-gated Ca2+ channel to allow Ca2+ entry into 
the β cells, resulting in an increase in cytoplasmic Ca2+. The 
Ca2+ then triggers the exocytosis of granules containing the 
insulin. Hence, control and changes in the membrane poten-
tial are key in determining insulin secretion and energetic 
control. Hypothesizing that as a Cl channel, CFTR may 
regulate β cell membrane potential and impaired CFTR ac-
tivity may lead to impaired insulin secretion, Chan et al. set 
to test this hypothesis. 
Dr. Chan and colleagues first showed that β cells express 
CFTR and CFTR is activated by glucose to increase Cl 
current and control intracellular Cl concentration in these 
cells. Most notably, the most common human mutation that 
causes CF, ΔF508, when introduced in mice, caused hy-
perpolarization of the β cell membrane potential. Moreover, 
manipulation of CFTR activity showed that CFTR Cl cur-
rent was required to prevent hyperpolarization of the mem-
brane potential. Absence of CFTR activity was sufficient to 
reduce the depolarization caused by glucose-mediated inhi-
bition of the ATP-regulated K+ channels. Thus, in the ab-
sence of CFTR activity, the glucose-evoked β cell action 
potentials were reduced and consequently insulin secretion.      
As expected from the findings with β cells, mice with 
mutated CFTR have lower insulin levels than wild-type 
mice, and show reduced response to glucose. Most excitedly, 
Dr. Chan and co-workers showed that treatment of the mice 
with drugs developed to treat CF also corrected insulin se-
cretion. These drugs are already in the clinic or are being 
tested with patients, thus they are very promising therapy in 
CF patients and may be even used in other forms of diabetes 
to boost insulin secretion. 
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